19-ETHYL-19-HYDROXY-14,18-DIOXO-17-OXA-3,13-DIAZAPENTACYCLO(11.8.0.02,11.04,9.015,20)HENICOSA-1(21),2(11),3,5,7,9,15(20)-HEPTAENE-6-CARBALDEHYDE, (19S)-
UNII 8ACM9TD3HF

Substance Identification & Data

This profile provides standardized clinical and technical data for 19-ethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo(11.8.0.02,11.04,9.015,20)henicosa-1(21),2(11),3,5,7,9,15(20)-heptaene-6-carbaldehyde, (19s)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 8ACM9TD3HF.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 135415-69-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

8ACM9TD3HF

CAS Registry Number

135415-69-9

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

19-ETHYL-19-HYDROXY-14,18-DIOXO-17-OXA-3,13-DIAZAPENTACYCLO(11.8.0.02,11.04,9.015,20)HENICOSA-1(21),2(11),3,5,7,9,15(20)-HEPTAENE-6-CARBALDEHYDE, (19S)-

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C21H16N2O5

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

AMDHQGZVCWWZCS-NRFANRHFSA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

13891186

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C(C)[C@]1(O)c2c(c(=O)n3c(c2)-c4c(C3)cc5c(n4)cc(C=O)cc5)COC1=O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for 19-ethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo(11.8.0.02,11.04,9.015,20)henicosa-1(21),2(11),3,5,7,9,15(20)-heptaene-6-carbaldehyde, (19s)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Systematic Nomenclature

(4S)-4-ETHYL-3,4,12,14-TETRAHYDRO-4-HYDROXY-3,14-DIOXO-1H-PYRANO(3',4':6,7)INDOLIZINO(1,2-B)QUINOLINE-8-CARBOXALDEHYDE

SYS

19-ETHYL-19-HYDROXY-14,18-DIOXO-17-OXA-3,13-DIAZAPENTACYCLO(11.8.0.02,11.04,9.015,20)HENICOSA-1(21),2(11),3,5,7,9,15(20)-HEPTAENE-6-CARBALDEHYDE, (19S)-

SYS

1H-PYRANO(3',4':6,7)INDOLIZINO(1,2-B)QUINOLINE-8-CARBOXALDEHYDE, 4-ETHYL-3,4,12,14-TETRAHYDRO-4-HYDROXY-3,14-DIOXO-, (4S)-

SYS

1H-PYRANO(3',4':6,7)INDOLIZINO(1,2-B)QUINOLINE-8-CARBOXALDEHYDE, 4-ETHYL-3,4,12,14-TETRAHYDRO-4-HYDROXY-3,14-DIOXO-, (S)-

SYS